Mesoblast Company Update - Webcast and Forward Thoughts, page-9

  1. 4,422 Posts.
    lightbulb Created with Sketch. 5753
    My understanding is they could if they wanted to, but they don't have any ARDS data until the trial is unblinded, which won't be until 2021 unless extreme efficacy occurs.

    They could use the results to link TNFR1 with a reduction in inflammation once they have the results.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.59
Change
-0.025(1.55%)
Mkt cap ! $2.031B
Open High Low Value Volume
$1.61 $1.62 $1.57 $6.345M 3.987M

Buyers (Bids)

No. Vol. Price($)
6 44493 $1.59
 

Sellers (Offers)

Price($) Vol. No.
$1.59 4159 1
View Market Depth
Last trade - 16.10pm 08/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.